• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-羟色胺2(HT2)受体拮抗剂酮色林对人体的急性电生理效应。

Acute electrophysiologic effects of an HT2-serotonin antagonist, ketanserin, in humans.

作者信息

Kaye G C, Mehta D, Wafa S, Camm A J

机构信息

Department of Cardiovascular Studies, St. George's Hospital, Medical School, London, UK.

出版信息

Cardiovasc Drugs Ther. 1990 Aug;4(4):1157-60. doi: 10.1007/BF01856513.

DOI:10.1007/BF01856513
PMID:2083196
Abstract

The acute electrophysiologic effects of an intravenous bolus of ketanserin, a 5HT2 serotonin blocker, were studied in ten patients (four females, six males) during invasive electrophysiology. Following baseline electrophysiologic measurements during sinus rhythm and fixed-rate atrial pacing at 600 ms, a bolus of 0.2 mg/kg ketanserin was given over a 3-minute period. After 30 minutes all measurements were repeated. Systemic blood pressure was measured at regular intervals throughout. During sinus rhythm, there was no significant change in the basic cycle length or in the PA, AH, HV, QRS, QT, and QTc intervals. During atrial pacing there was a nonsignificant increase in the QT interval, from 342 +/- 13 ms to 366 +/- 16 ms, and a significant increase in the QTc interval, from 422 +/- 27 ms to 449 +/- 29 ms (p less than 0.05). There was no reduction in blood pressure. Thus ketanserin produced a significant prolongation of the QTc interval, in the absence of hypokalemia, in humans.

摘要

在侵入性电生理检查过程中,对10例患者(4例女性,6例男性)研究了静脉注射5HT2血清素阻滞剂酮色林的急性电生理效应。在窦性心律和600毫秒的固定频率心房起搏期间进行基线电生理测量后,在3分钟内静脉推注0.2毫克/千克的酮色林。30分钟后重复所有测量。在整个过程中定期测量全身血压。在窦性心律期间,基本周期长度或PA、AH、HV、QRS、QT和QTc间期均无显著变化。在心房起搏期间,QT间期从342±13毫秒非显著增加至366±16毫秒,QTc间期从422±27毫秒显著增加至449±29毫秒(p<0.05)。血压没有降低。因此,在无低钾血症的情况下,酮色林可使人类QTc间期显著延长。

相似文献

1
Acute electrophysiologic effects of an HT2-serotonin antagonist, ketanserin, in humans.5-羟色胺2(HT2)受体拮抗剂酮色林对人体的急性电生理效应。
Cardiovasc Drugs Ther. 1990 Aug;4(4):1157-60. doi: 10.1007/BF01856513.
2
Cardiac electrophysiologic effects of intravenous ketanserin in humans.静脉注射酮色林对人体心脏电生理的影响。
J Cardiovasc Pharmacol. 1987;10 Suppl 3:S81-5.
3
Effects of short-term ketanserin treatment on the QT interval and vagal function in healthy subjects.短期服用酮色林对健康受试者QT间期和迷走神经功能的影响。
J Auton Pharmacol. 1989 Feb;9(1):45-51. doi: 10.1111/j.1474-8673.1989.tb00195.x.
4
Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.选择性延长不应期的抗心律失常作用。盐酸塞美利定在人体的电生理作用。
Circulation. 1993 Sep;88(3):1072-82. doi: 10.1161/01.cir.88.3.1072.
5
QT prolongation and torsade de pointes ventricular tachycardia produced by Ketanserin.酮色林引起的QT间期延长和尖端扭转型室性心动过速。
Pacing Clin Electrophysiol. 1986 Nov;9(6):836-41. doi: 10.1111/j.1540-8159.1986.tb06633.x.
6
Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease.静脉注射镁对传导系统正常且无明显心脏病临床证据患者的电生理效应。
Am Heart J. 1988 Feb;115(2):367-73. doi: 10.1016/0002-8703(88)90483-8.
7
Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin. Multicenter Ketanserin Research Group.新型选择性5-羟色胺拮抗剂酮色林所致QT间期延长的发生率及临床相关性。多中心酮色林研究组
Clin Physiol Biochem. 1990;8 Suppl 3:90-100.
8
The electrophysiological effects of flosequinan.氟西喹南的电生理效应。
Eur Heart J. 1991 Dec;12(12):1288-92. doi: 10.1093/eurheartj/12.12.1288.
9
Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
Am Heart J. 1983 May;105(5):811-9. doi: 10.1016/0002-8703(83)90245-4.
10
Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin.新型选择性5-羟色胺拮抗剂酮色林所致QT间期延长的发生率及临床相关性。
Am J Cardiol. 1989 Apr 1;63(12):826-32. doi: 10.1016/0002-9149(89)90051-9.

引用本文的文献

1
Mood disorders, circadian rhythms, melatonin and melatonin agonists.情绪障碍、昼夜节律、褪黑素及褪黑素激动剂。
J Cent Nerv Syst Dis. 2012 Jan 4;4:15-26. doi: 10.4137/JCNSD.S4103. Print 2012.

本文引用的文献

1
The measurement of the Q-T interval of the electrocardiogram.心电图Q-T间期的测量。
Circulation. 1952 Sep;6(3):378-88. doi: 10.1161/01.cir.6.3.378.
2
Sotalol, hypokalaemia, syncope, and torsade de pointes.索他洛尔、低钾血症、晕厥与尖端扭转型室性心动过速
Br Heart J. 1984 Feb;51(2):157-62. doi: 10.1136/hrt.51.2.157.
3
Mechanism of the hypotensive effect of ketanserin.酮色林降压作用的机制。
J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):829-38. doi: 10.1097/00005344-198209000-00020.
4
Is ketanserin a D receptor antagonist?酮色林是一种D受体拮抗剂吗?
Lancet. 1983 Mar 26;1(8326 Pt 1):703-4.
5
Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.高血压中的5-羟色胺能机制。聚焦于酮色林的作用。
Hypertension. 1988 Feb;11(2):111-33. doi: 10.1161/01.hyp.11.2.111.
6
Effect of intravenous ketanserin on the human action potential duration at fixed heart rate.静脉注射酮色林对固定心率下人体动作电位时程的影响。
Cardiovasc Drugs Ther. 1988 Jul;2(2):239-43. doi: 10.1007/BF00051240.
7
Ketanserin--a new antihypertensive agent.
J Hypertens Suppl. 1986 Apr;4(1):S13-6.
8
Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin.新型选择性5-羟色胺拮抗剂酮色林所致QT间期延长的发生率及临床相关性。
Am J Cardiol. 1989 Apr 1;63(12):826-32. doi: 10.1016/0002-9149(89)90051-9.
9
Cardiac electrophysiologic effects of intravenous ketanserin in humans.静脉注射酮色林对人体心脏电生理的影响。
J Cardiovasc Pharmacol. 1987;10 Suppl 3:S81-5.
10
Proarrhythmic effects of antiarrhythmic drugs.抗心律失常药物的促心律失常作用。
Am J Cardiol. 1987 Apr 30;59(11):26E-31E. doi: 10.1016/0002-9149(87)90198-6.